2016年开滦糖尿病前瞻性队列(INDEED项目)数据表格
收藏资源简介:
(1)数据内容:采用前瞻性队观察性队列研究设计。筛选出DKD患者纳入本研究,采集包括患者一般情况、病史、血/尿各项检验指标。 (2)采集方案:对筛选出来的病人拟进行每年一次的随访,病人随访流程-签署知情同意书(仅限于基线访视),填写研究问卷,研究医生需协助病人在随访时完成本研究的所有问卷的填写,填写完成后,问卷需在各研究中心进行妥善保管。 (3)采集生物学标本:本研究将搜集病人约10ml血和15ml尿标本,用于检测糖化血红蛋白,血肌酐和尿蛋白肌酐比值,尿微量白蛋白肌酐比值等项目,并将保存部分血尿标本用于日后科研使用。所有标本通过常温或冷链运输至北大医院肾内科进行统一处理,所有检测结果均会返回开滦研究中心,供开放共享使用。
(1) Data Content: This study employs a prospective cohort observational study design. Patients diagnosed with diabetic kidney disease (DKD) were screened and enrolled in this research. General patient demographics, medical history, and comprehensive blood and urine laboratory test parameters were collected. (2) Collection Protocol: Eligible participants will undergo annual follow-up visits. The follow-up workflow is as follows: sign the informed consent form (only required for the baseline visit), complete the study questionnaires. Study physicians will assist participants in filling out all study questionnaires during follow-up, and all completed questionnaires shall be properly archived at each participating research site. (3) Biological Specimen Collection: Approximately 10 mL of blood and 15 mL of urine specimens will be collected from each participant for assays including glycated hemoglobin (HbA1c), serum creatinine, urine protein-to-creatinine ratio, urine microalbumin-to-creatinine ratio, and other relevant indicators. A portion of the collected blood and urine specimens will be preserved for future scientific research endeavors. All specimens will be transported to the Department of Nephrology, Peking University Hospital via either ambient temperature or cold chain logistics for unified processing and testing. All test results will be returned to the Kailuan Research Center for open access and shared utilization.




